柔合球体器官介导的恒温机制:对慢性病的治疗意义
Eiji Higashihara1, Takeo Harada2, Hiroshi Fukuhara1
1Department of Urology, Kyorin University School of Medicine, Mitaka, Japan.
Expert opinion on pharmacotherapy
|May 22, 2024
概括
柔合球体器官 (JGA) 机制影响了-葡萄糖共运输体2抑制剂 (SGLT2is) 如何治疗慢性病 (CKD) 以及托尔瓦普坦如何影响自身主导性多囊性病 (ADPKD). 这种理解可能会改善病的治疗方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 身体生理学 身体生理学
背景情况:
- 配细胞器 (JGA) 在的恒温中起着至关重要的作用.
- JGA的功能与管球球体反和氨酸-血管素系统有关.
- -葡萄糖共运输体2抑制剂 (SGLT2is) 和托尔瓦普坦是治疗病的关键药物.
研究的目的:
- 为了探索JGA介导的恒温机制.
- 评估JGA机制与慢性脏病 (CKD) 中SGLT2is治疗效果之间的关系.
- 评估JGA机制与托尔瓦普坦在自身主导多性病 (ADPKD) 中的益处之间的潜在联系.
主要方法:
- 对涉及SGLT2is和tolvaptan的临床试验的审查.
- 对JGA介导的恒温机制的分析,包括管球球体反.
- 检查斑点密度 (MD) 信号,以应对负载.
主要成果:
- 斑点密度 (MD) 增加的负载会触发腺的产生,从而收窄 afferent arteriole (Af-art) 以保护质细胞.
- MD信号抑制氨酸分泌,增强分泌,平衡过.
- 在晚期的CKD中,增加的MD腺生产可能会放松 afferent动脉 (Af-art),以支付质细胞的代价维持平衡.
结论:
- 通过JGA介导的平静机制对于了解SGLT2i在CKD中的疗效至关重要.
- 托尔瓦普坦在ADPKD中对脏的益处可能涉及JGA介导的机制,因为它对再吸收的作用.
- 进一步了解JGA机制可以指导脏疾病的新药疗法的开发.
相关概念视频
01:33Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
01:28Glomerular Filtration Rate and its Regulation
2.6K
The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
2.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
01:13Introduction to Urinary System
2.5K
The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
2.5K
01:18Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
618
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
618